skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 652  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Insidehealthpolicy.Com's Fda Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
FDA Official Rebuts Patient Advocates’ Biosimilar Concerns
Material Type:
Article
Add to My Research

FDA Official Rebuts Patient Advocates’ Biosimilar Concerns

InsideHealthPolicy.com's FDA Week, 2018-09, Vol.24 (37), p.5-6

Copyright Inside Washington Publishers Sep 14, 2018 ;ISSN: 2165-4166

Full text available

2
CMS PROPOSES TO LET RX PLANS USE NON-INTERCHANGEABLE BIOSIMILARS
Material Type:
Article
Add to My Research

CMS PROPOSES TO LET RX PLANS USE NON-INTERCHANGEABLE BIOSIMILARS

InsideHealthPolicy.com's FDA Week, 2023-11, Vol.29 (45)

Copyright Inside Washington Publishers Nov 10, 2023 ;ISSN: 2165-4166

Full text available

3
FDA REMOTE EVALUATIONS VOLUNTARY, BUT DECLINING COULD DELAY REG ACTION
Material Type:
Article
Add to My Research

FDA REMOTE EVALUATIONS VOLUNTARY, BUT DECLINING COULD DELAY REG ACTION

InsideHealthPolicy.com's FDA Week, 2023-11, Vol.29 (44)

Copyright Inside Washington Publishers Nov 3, 2023 ;ISSN: 2165-4166

Full text available

4
MODERNA IS FIRST TO SEEK FDA AUTHORIZATION FOR XBB.1.5 COVID VAX
Material Type:
Article
Add to My Research

MODERNA IS FIRST TO SEEK FDA AUTHORIZATION FOR XBB.1.5 COVID VAX

InsideHealthPolicy.com's FDA Week, 2023-06, Vol.29 (26)

Copyright Inside Washington Publishers Jun 30, 2023 ;ISSN: 2165-4166

Full text available

5
FDA SELECTS XBB.1.5 AS TARGET FOR FALL COVID VAX ROLLOUT
Material Type:
Article
Add to My Research

FDA SELECTS XBB.1.5 AS TARGET FOR FALL COVID VAX ROLLOUT

InsideHealthPolicy.com's FDA Week, 2023-06, Vol.29 (25)

Copyright Inside Washington Publishers Jun 23, 2023 ;ISSN: 2165-4166

Full text available

6
FDA: GENERAL SCIENTIFIC KNOWLEDGE CAN SUPPORT, SPEED DRUG APPROVALS
Material Type:
Article
Add to My Research

FDA: GENERAL SCIENTIFIC KNOWLEDGE CAN SUPPORT, SPEED DRUG APPROVALS

InsideHealthPolicy.com's FDA Week, 2023-06, Vol.29 (22)

Copyright Inside Washington Publishers Jun 2, 2023 ;ISSN: 2165-4166

Full text available

7
FDA GUIDE THAT MAY OPEN PATH TO BRANDED BIOSIMILARS CLEARS OMB
Material Type:
Article
Add to My Research

FDA GUIDE THAT MAY OPEN PATH TO BRANDED BIOSIMILARS CLEARS OMB

InsideHealthPolicy.com's FDA Week, 2020-03, Vol.26 (10)

Copyright Inside Washington Publishers Mar 6, 2020 ;ISSN: 2165-4166

Full text available

8
OMB REVIEWING BIOLOGICS GUIDE THAT MIGHT LEAD TO BRANDED BIOSIMILARS
Material Type:
Article
Add to My Research

OMB REVIEWING BIOLOGICS GUIDE THAT MIGHT LEAD TO BRANDED BIOSIMILARS

InsideHealthPolicy.com's FDA Week, 2020-02, Vol.26 (9)

Copyright Inside Washington Publishers Feb 28, 2020 ;ISSN: 2165-4166

Full text available

9
WHO Unveils Final Biological Naming Plan That Differs From FDA’s
Material Type:
Article
Add to My Research

WHO Unveils Final Biological Naming Plan That Differs From FDA’s

InsideHealthPolicy.com's FDA Week, 2016-01, Vol.22 (4), p.1-11

Copyright Inside Washington Publishers Jan 29, 2016 ;ISSN: 2165-4166

Full text available

10
FDA Backtracks On Contentious Interchangeability Study Requirement
Material Type:
Article
Add to My Research

FDA Backtracks On Contentious Interchangeability Study Requirement

InsideHealthPolicy.com's FDA Week, 2018-07, Vol.24 (29), p.8-8

Copyright Inside Washington Publishers Jul 20, 2018 ;ISSN: 2165-4166

Full text available

11
BIPARTISAN SENATE BILL WOULD SPEED INTERCHANGEABLE BIOSIMILAR COMPETITION
Material Type:
Article
Add to My Research

BIPARTISAN SENATE BILL WOULD SPEED INTERCHANGEABLE BIOSIMILAR COMPETITION

InsideHealthPolicy.com's FDA Week, 2022-05, Vol.28 (21)

Copyright Inside Washington Publishers May 27, 2022 ;ISSN: 2165-4166

Full text available

12
CDER OFFICIAL URGES BIOSIMILARS MAKERS TO FOCUS ON QUALITY
Material Type:
Article
Add to My Research

CDER OFFICIAL URGES BIOSIMILARS MAKERS TO FOCUS ON QUALITY

InsideHealthPolicy.com's FDA Week, 2023-11, Vol.29 (44)

Copyright Inside Washington Publishers Nov 3, 2023 ;ISSN: 2165-4166

Full text available

13
REGULATORY AGENDA INCLUDES 340B, BIOSIMILAR, OTC DRUG MEASURES
Material Type:
Article
Add to My Research

REGULATORY AGENDA INCLUDES 340B, BIOSIMILAR, OTC DRUG MEASURES

InsideHealthPolicy.com's FDA Week, 2021-12, Vol.27 (50)

Copyright Inside Washington Publishers Dec 17, 2021 ;ISSN: 2165-4166

Full text available

14
FDA ADVISERS RECOMMEND MONOVALENT XBB COVID VAX FOR FALL
Material Type:
Article
Add to My Research

FDA ADVISERS RECOMMEND MONOVALENT XBB COVID VAX FOR FALL

InsideHealthPolicy.com's FDA Week, 2023-06, Vol.29 (25)

Copyright Inside Washington Publishers Jun 23, 2023 ;ISSN: 2165-4166

Full text available

15
FDA REVISES DRAFT GUIDE WITH DETAILS ON ADJUSTING FOR COVARIATES IN TRIALS
Material Type:
Article
Add to My Research

FDA REVISES DRAFT GUIDE WITH DETAILS ON ADJUSTING FOR COVARIATES IN TRIALS

InsideHealthPolicy.com's FDA Week, 2021-05, Vol.27 (21)

Copyright Inside Washington Publishers May 28, 2021 ;ISSN: 2165-4166

Full text available

16
FDA: DON'T IMPLY REFERENCE DRUGS, INTERCHANGEABLES BETTER THAN BIOSIMS
Material Type:
Article
Add to My Research

FDA: DON'T IMPLY REFERENCE DRUGS, INTERCHANGEABLES BETTER THAN BIOSIMS

InsideHealthPolicy.com's FDA Week, 2024-04, Vol.30 (17)

Copyright Inside Washington Publishers Apr 26, 2024 ;ISSN: 2165-4166

Full text available

17
ASBM Uses European Biosimilar Naming Survey To Push Unique Names
Material Type:
Article
Add to My Research

ASBM Uses European Biosimilar Naming Survey To Push Unique Names

InsideHealthPolicy.com's FDA Week, 2013-11, Vol.19 (48), p.2-2

Copyright Inside Washington Publishers Nov 27, 2013 ;ISSN: 2165-4166

Full text available

18
SENATE PARLIAMENTARIAN AXES COMMERCIAL INFLATION CAPS
Material Type:
Article
Add to My Research

SENATE PARLIAMENTARIAN AXES COMMERCIAL INFLATION CAPS

InsideHealthPolicy.com's FDA Week, 2022-08, Vol.28 (32)

Copyright Inside Washington Publishers Aug 12, 2022 ;ISSN: 2165-4166

Full text available

19
PRESIDENT'S BUDGET CALLS FOR UNRESTRICTED BIOSIMILAR SWITCHING
Material Type:
Article
Add to My Research

PRESIDENT'S BUDGET CALLS FOR UNRESTRICTED BIOSIMILAR SWITCHING

InsideHealthPolicy.com's FDA Week, 2024-03, Vol.30 (11)

Copyright Inside Washington Publishers Mar 15, 2024 ;ISSN: 2165-4166

Full text available

20
COHERUS: FAVORED-NATION DEMO UNDERMINES BIOSIMILARS
Material Type:
Article
Add to My Research

COHERUS: FAVORED-NATION DEMO UNDERMINES BIOSIMILARS

InsideHealthPolicy.com's FDA Week, 2020-12, Vol.26 (49)

Copyright Inside Washington Publishers Dec 4, 2020 ;ISSN: 2165-4166

Full text available

Results 1 - 20 of 652  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2013  (30)
  2. 2013 To 2014  (76)
  3. 2015 To 2016  (133)
  4. 2017 To 2019  (145)
  5. After 2019  (268)
  6. More options open sub menu

Searching Remote Databases, Please Wait